Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab
- 18 November 2005
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 154 (1) , 191-192
- https://doi.org/10.1111/j.1365-2133.2005.07010.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The promise of molecular targeted therapies: Protein kinase inhibitors in the treatment of cutaneous malignanciesPublished by Elsevier ,2005
- Practical Management of Patients With Non–Small-Cell Lung Cancer Treated With GefitinibJournal of Clinical Oncology, 2005
- Complications of Therapy in Cancer PatientsJournal of Clinical Oncology, 2004
- Dermatologic Side Effects Associated with Gefitinib Therapy: Clinical Experience and ManagementClinical Lung Cancer, 2003
- Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225British Journal of Dermatology, 2001
- Paronychia associated with antiretroviral therapyBritish Journal of Dermatology, 1999
- Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial MechanismsAdvances in Dental Research, 1998
- Retinoids and the nailsJournal of Dermatological Treatment, 1990
- Paronychia and pyogenic granuloma-like lesions with isotretinoinJournal of the American Academy of Dermatology, 1984